192 related articles for article (PubMed ID: 19370612)
1. Interventions for American cutaneous and mucocutaneous leishmaniasis.
González U; Pinart M; Rengifo-Pardo M; Macaya A; Alvar J; Tweed JA
Cochrane Database Syst Rev; 2009 Apr; (2):CD004834. PubMed ID: 19370612
[TBL] [Abstract][Full Text] [Related]
2. Interventions for American cutaneous and mucocutaneous leishmaniasis.
Pinart M; Rueda JR; Romero GA; Pinzón-Flórez CE; Osorio-Arango K; Silveira Maia-Elkhoury AN; Reveiz L; Elias VM; Tweed JA
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD004834. PubMed ID: 32853410
[TBL] [Abstract][Full Text] [Related]
3. Interventions for Old World cutaneous leishmaniasis.
González U; Pinart M; Reveiz L; Alvar J
Cochrane Database Syst Rev; 2008 Oct; (4):CD005067. PubMed ID: 18843677
[TBL] [Abstract][Full Text] [Related]
4. Interventions for Old World cutaneous leishmaniasis.
Heras-Mosteiro J; Monge-Maillo B; Pinart M; Lopez Pereira P; Reveiz L; Garcia-Carrasco E; Campuzano Cuadrado P; Royuela A; Mendez Roman I; López-Vélez R
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD005067. PubMed ID: 29149474
[TBL] [Abstract][Full Text] [Related]
5. Interventions for Old World cutaneous leishmaniasis.
Heras-Mosteiro J; Monge-Maillo B; Pinart M; Lopez Pereira P; Reveiz L; Garcia-Carrasco E; Campuzano Cuadrado P; Royuela A; Mendez Roman I; López-Vélez R
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD005067. PubMed ID: 29192424
[TBL] [Abstract][Full Text] [Related]
6. Interventions for American cutaneous and mucocutaneous leishmaniasis: a systematic review update.
Reveiz L; Maia-Elkhoury AN; Nicholls RS; Romero GA; Yadon ZE
PLoS One; 2013; 8(4):e61843. PubMed ID: 23637917
[TBL] [Abstract][Full Text] [Related]
7. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study.
Soto J; Fuya P; Herrera R; Berman J
Clin Infect Dis; 1998 Jan; 26(1):56-8. PubMed ID: 9455509
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.
Armijos RX; Weigel MM; Calvopiña M; Mancheno M; Rodriguez R
Acta Trop; 2004 Jul; 91(2):153-60. PubMed ID: 15234664
[TBL] [Abstract][Full Text] [Related]
9. Comparative assessment of interventions for treating cutaneous leishmaniasis: A network meta-analysis of randomized clinical trials.
Sridharan K; Sivaramakrishnan G
Acta Trop; 2021 Aug; 220():105944. PubMed ID: 33957088
[TBL] [Abstract][Full Text] [Related]
10. Treatment of New World cutaneous and mucosal leishmaniases.
Berman JD
Clin Dermatol; 1996; 14(5):519-22. PubMed ID: 8889330
[TBL] [Abstract][Full Text] [Related]
11. Combined suboptimal schedules of topical paromomycin, meglumine antimoniate and miltefosine to treat experimental infection caused by Leishmania (Viannia) braziliensis.
de Morais-Teixeira E; Aguiar MG; Soares de Souza Lima B; Ferreira LA; Rabello A
J Antimicrob Chemother; 2015 Dec; 70(12):3283-90. PubMed ID: 26346991
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous leishmaniasis treatment.
Minodier P; Parola P
Travel Med Infect Dis; 2007 May; 5(3):150-8. PubMed ID: 17448941
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.
Monge-Maillo B; López-Vélez R
Drugs; 2013 Nov; 73(17):1889-920. PubMed ID: 24170665
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate.
Soto J; Hernandez N; Mejia H; Grogl M; Berman J
Clin Infect Dis; 1995 Jan; 20(1):47-51. PubMed ID: 7727669
[TBL] [Abstract][Full Text] [Related]
15. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
[TBL] [Abstract][Full Text] [Related]
16. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
El-Sayed M; Anwar AE
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):335-40. PubMed ID: 19744259
[TBL] [Abstract][Full Text] [Related]
17. A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis.
Rodrigues BC; Ferreira MF; Barroso DH; Motta JOCD; Paula CDR; Porto C; Martins SS; Gomes CM; Sampaio RNR
Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():257-263. PubMed ID: 33285343
[TBL] [Abstract][Full Text] [Related]
18. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.
Pienaar ED; Young T; Holmes H
Cochrane Database Syst Rev; 2006 Jul; (3):CD003940. PubMed ID: 16856025
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of allylamines in the treatment of cutaneous and mucocutaneous leishmaniasis: A systematic review.
Bezemer JM; van der Ende J; Limpens J; de Vries HJC; Schallig HDFH
PLoS One; 2021; 16(4):e0249628. PubMed ID: 33826660
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients.
Cabrera M; Blackwell JM; Castes M; Trujillo D; Convit J; Shaw MA
Parasite Immunol; 2000 Feb; 22(2):73-9. PubMed ID: 10652119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
